NORTHWEST BIOTHERAPEUTICS INC Interest Expense Nonoperating
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Interest Expense Nonoperating of $1.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- NORTHWEST BIOTHERAPEUTICS INC interest expense nonoperating for the quarter ending 2026-06-30 was $1.81M, a 0.93% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC interest expense nonoperating for the quarter ending 2026-03-31 was $2.35M, a 46.44% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC interest expense nonoperating for the quarter ending 2025-12-31 was $2.65M, a 6.35% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC interest expense nonoperating for the quarter ending 2025-09-30 was $2.62M, a 26.01% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC interest expense nonoperating for fiscal 2025 was $8.70M, a 11.95% increase from fiscal 2024.
- NORTHWEST BIOTHERAPEUTICS INC interest expense nonoperating for fiscal 2024 was $7.77M, a 48.20% increase from fiscal 2023.
- NORTHWEST BIOTHERAPEUTICS INC interest expense nonoperating for fiscal 2023 was $5.24M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.81M 10-Q · filed 2026-08-14 | $4.16M 10-Q · filed 2026-08-14 | $6.80M derived: sum of 3 quarters · filed 2026-08-14 | $9.42M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.35M 10-Q · filed 2026-05-15 | $4.99M derived: sum of 2 quarters · filed 2026-05-15 | $7.61M derived: sum of 3 quarters · filed 2026-05-15 | $9.44M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $5.27M derived: sum of 2 quarters · filed 2026-04-15 | $7.09M derived: sum of 3 quarters · filed 2026-08-14 | $8.70M 10-K · filed 2026-04-15 |
| 2025-09-30 | $2.62M 10-Q · filed 2025-11-14 | $4.45M derived: sum of 2 quarters · filed 2026-08-14 | $6.05M 10-Q · filed 2025-11-14 | $8.54M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.83M 10-Q · filed 2026-08-14 | $3.43M 10-Q · filed 2026-08-14 | $5.92M derived: sum of 3 quarters · filed 2026-08-14 | $8.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.60M 10-Q · filed 2026-05-15 | $4.09M derived: sum of 2 quarters · filed 2026-05-15 | $6.17M derived: sum of 3 quarters · filed 2026-05-15 | $7.85M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $4.57M derived: sum of 2 quarters · filed 2026-04-15 | $6.25M derived: sum of 3 quarters · filed 2026-04-15 | $7.77M 10-K · filed 2026-04-15 |
| 2024-09-30 | $2.08M 10-Q · filed 2025-11-14 | $3.76M derived: sum of 2 quarters · filed 2025-11-14 | $5.28M 10-Q · filed 2025-11-14 | $6.52M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.68M 10-Q · filed 2025-08-14 | $3.20M 10-Q · filed 2025-08-14 | $4.44M derived: sum of 3 quarters · filed 2025-08-14 | $6.11M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.52M 10-Q · filed 2025-05-15 | $2.76M derived: sum of 2 quarters · filed 2025-05-15 | $4.43M derived: sum of 3 quarters · filed 2025-05-15 | $5.73M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.91M derived: sum of 2 quarters · filed 2025-03-31 | $4.21M derived: sum of 3 quarters · filed 2025-03-31 | $5.24M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.67M 10-Q · filed 2024-11-12 | $2.97M derived: sum of 2 quarters · filed 2024-11-12 | $4.00M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.30M 10-Q · filed 2024-08-09 | $2.33M 10-Q · filed 2024-08-09 |